Skip to main content
. 2019 Jan 29;10:8. doi: 10.1186/s13244-019-0690-1

Fig. 8.

Fig. 8

Hepatic focal lesions after TACE. a, b T2-WI shows two well-defined HFLs of an intermediate to high signal (white arrows) with central biliary dilatation (red arrow). c, d Subtracted T1-WI arterial phase shows no enhancement of the lesions. Overall post-treatment assessment is LR-TR nonviable with post-therapy biliary dilatation